Skip to main content
. Author manuscript; available in PMC: 2016 Jul 25.
Published in final edited form as: J Am Coll Cardiol. 2016 Jan 5;67(1):29–38. doi: 10.1016/j.jacc.2015.10.046

Figure 1. Sensitivity Analysis on Total Costs for Index TAVR Admissions.

Figure 1

The impact of reduced index TAVR admission costs on the ICER for TAVR versus SAVR, shown as $/QALY gained (red line) or $/LY gained (blue line). Reductions of ~$1,650 per admission would result in the ICERs falling below the threshold of $50,000 per QALY gained, considered to represent high economic value. ICER = incremental cost-effectiveness ratio; LY = life-year; QALY = quality-adjusted life-year; SAVR = surgical aortic valve replacement; TAVR = transcatheter aortic valve replacement.